Sexual Medicine · 2016 · 21 citations · 21 references
MedicineEndocrinologyGeneticsHuman GeneticsPharmacogeneticsPharmacogenomicsAndrogen PhysiologyGenotype-phenotype CorrelationHair DisordersHormonal InfluencesHormone Receptor GeneticsReceptor PolymorphismsAndrogen Receptor GeneticsFinasteride TherapyGenetic Basis Of AlopeciaMedication Adverse EffectsNuclear Receptor PolymorphismsPatient-reported Skin SymptomsReceptor Polymorphism AnalysisReceptor Polymorphism Effects
INTRODUCTION: Long-term adverse symptoms of men who used oral finasteride against androgenic alopecia have been recently described as post-finasteride syndrome (PFS). AIM: To determine whether (CAG)n-rs4045402 and (GGN)n-rs3138869 polymorphisms in the androgen receptor (AR) gene are implicated in PFS. METHODS: AR polymorphisms were studied according to PFS symptoms in 66 white participants (31.8% Italian, 28.8% American, and 39.4% other). MAIN OUTCOME MEASURES: Symptoms were investigated by an ad hoc 100-item questionnaire and the Arizona Sexual Experience Scale and Aging Male Symptom Scale (AMS). (CAG)n and (GGN)n repeats were categorized as short ([CAG]9-19, [GGN]<23), medium ([CAG]20-24, [GGN]23), or long ([CAG]25-37, [GGN]>23). RESULTS: Median age was 32 years, duration of finasteride use was 360 days, and time from finasteride discontinuation was 1,053 days. We observed several frequency differences in symptoms according to (CAG)n and (GGN)n repeat numbers. Three AMS items were worse for medium (GGN)23 than for long (GGN)>23 carriers and one item was worse for short (GGN)<23 carriers. The AMS item for decrease in sexual desire or libido was worse for short (CAG)9-19 carriers than for medium (CAG)20-24 carriers. Through the ad hoc questionnaire, significant findings in (CAG)n and/or (GGN)n repeats were obtained for penile discomfort, loss of scrotal sensitivity, scrotal discomfort, less pubic hair, loss of perceived perineal fullness, increased sperm density, involuntary muscle spasms, loss of muscle tone, increased weight (>2 kg), increased skin dryness, and onset of symptoms after finasteride use. CONCLUSION: This study showed that short and/or long (CAG)n and (GGN)n repeats had different frequencies according to symptoms reported by patients with PFS, likely reflecting the vast array of genes modulated by the AR. This study showed a U-curvilinear profile of (CAG)n repeats for skin dryness symptoms, where the two extremes exhibited a worse condition than medium repeats. Further studies are necessary to investigate the PFS pathophysiology using a precision medicine approach.
21
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Albert R. La Spada, Elizabeth Wilson, Dennis B. Lubahn et al. · Nature · 1991 · 2.8K citations
The androgen receptor gene mutations database: 2012 update
Bruce Gottlieb, Lenore K. Beitel, Abbesha Nadarajah et al. · Human Mutation · 2012 · 506 citations
S. Faisal Ahmed, Anna Wai-Fun Cheng, L. Dovey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 316 citations · Full text
Medicine, Endocrinology, Pediatrics +15